Protocol › Age criteria · Last reviewed 2026-05-16
Age criteria and Tanner stages
Summary
The original Dutch Protocol set thresholds at Tanner stage 2 (about 11–12 years) for puberty suppression, 16 for cross-sex hormones and 18 for surgery. The Endocrine Society guideline of 2017 maintained these benchmarks but allowed hormones to begin before age 16 in selected cases, with documented consent of the patient and parents.
1. Tanner stages
The Tanner stages (1962) describe the progression of sexual maturation. The Dutch Protocol uses the Tanner stage as a criterion for starting GnRH agonists:
| Tanner | Feature girls | Feature boys | Age (mean) |
|---|---|---|---|
| 1 | Prepubertal | Prepubertal | < 10–11 |
| 2 | Beginning breast development (thelarche) | Testicular volume 4 ml+ | 10–12 |
| 3 | Further breast development, pubic hair | Voice change begins | 12–13 |
| 4 | Breast development almost complete | Facial hair | 13–15 |
| 5 | Adult | Adult | 15+ |
2. Original age thresholds
| Intervention | Minimum criterion | Source |
|---|---|---|
| GnRH agonist | Tanner 2 (~12 years) | Delemarre 2006 |
| Cross-sex hormones | 16 years | Delemarre 2006 |
| Surgery | 18 years | Delemarre 2006 |
3. Adjustments under Endocrine Society 2017
The Endocrine Society in its revised guideline (2017) allowed cross-sex hormones to start "earlier than 16 years" in selected cases, on the basis of "compelling reasons" and with consent of patient and parents.1 This relaxation was criticised by various later authors as a deviation from the original Dutch design; see WPATH SOC and the Dutch Protocol.
4. Application in later international practice
In UK GIDS practice GnRH agonists were in some cases prescribed after only one diagnostic appointment and at ages down to about 10 years.2 This deviation from the Dutch criteria is a central concern in the Cass Review (2024). Finland (COHERE 2020) and the UK have applied age thresholds more strictly since 2020.
Critical note
The age thresholds used are not based on empirical research into the optimal start age, but on pragmatic clinical considerations (pubertal stage, legal majority). SBU (2022) and Cass (2024) note that there are no comparative studies indicating whether, for example, Tanner 3 or 4 — a later start — would yield different outcomes. The Tanner 2 threshold in practice means that many adolescents are treated well before sexuality and abstract reasoning have developed.3
See also
- Original protocol description: Delemarre 2006
- How the thresholds relate to the phases: Three treatment phases
- WPATH relaxations: WPATH SOC
- Stricter international application: COHERE Finland, Cass Review
- UK deviation from Dutch criteria: Tavistock GIDS
- People register — Cohen-Kettenis, Delemarre, de Vries.
- International comparison — age thresholds per country.
- Timeline — protocol development chronologically.
- FAQ · Glossary · For parents.
Footnotes
- Hembree WC, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons. J Clin Endocrinol Metab. 2017;102(11):3869–903.
- Cass H. Independent review of gender identity services for children and young people: final report. NHS England; April 2024.
- SBU. Hormone therapy at gender dysphoria in adolescents. Stockholm; 2022. Report 327.